SS Innovations Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System
29 avr. 2024 08h00 HE
|
SS Innovations
SS Innovations Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
27 mars 2024 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing,...
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
04 mars 2024 08h00 HE
|
Quoin Pharmaceuticals, Inc.
Clearance to include teen patients in both the company’s open label and placebo controlled studies expected to significantly expand the number of eligible subjects, potentially expedite recruitment...
Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with AGAMREE
27 févr. 2024 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on...
Behavioral Health Market revenue to surpass USD 67 Billion by 2033, says Research Nester
22 janv. 2024 05h00 HE
|
Research Nester
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The global behavioral health market size is projected to expand at ~5% CAGR between 2023 and 2033. The market is expected to garner a revenue of USD 67...
Er-Kim Announces Exclusive Distribution Agreement with Ascendis Pharma A/S to Commercialize 3 Endocrinology Disease Treatments Across Central & Eastern Europe and Turkey
08 janv. 2024 18h01 HE
|
Er-Kim
Er-Kim is appointed as the exclusive Ascendis A/S endocrinology distributor across Central & Eastern Europe and Turkey
Accarent Health Announces Affiliation with Children’s Hospital Los Angeles to Provide Virtual Cardiology, Oncology and Musculoskeletal Second Opinion Services
02 janv. 2024 10h57 HE
|
Accarent Health
Baltimore, MD, Jan. 02, 2024 (GLOBE NEWSWIRE) -- When your child has a health condition, you want the best possible care. Children’s Hospital Los Angeles (CHLA) provides exceptional family-centered...
Behavioral Health Startup, ABC Medical, Offers Innovative Treatment Program
17 nov. 2023 14h59 HE
|
ABC Medical
Comprehensive treatment program for those experiencing mental illness
Pediatric Clinical Trials Market Size to Reach US$ 20.6 Billion by 2030, Driven by Increasing Prevalence of Chronic Diseases and Rising Demand for Pediatric-Specific Treatments
08 nov. 2023 06h01 HE
|
Rationalstat LLC
Wilmington, Delaware, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Global Pediatric Clinical Trials Market value is estimated at US$ 14.6 billion in 2023 and is expected to grow at a significant CAGR...
NeuroSigma Announces FDA 510(k) Submission for Second Generation Monarch eTNS System
07 nov. 2023 08h50 HE
|
NeuroSigma, Inc.
LOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its second-generation...